Publicaciones en las que colabora con Ignacio Pérez Valero (10)

2016

  1. Switching from tenofovir containing regimens to boosted protease inhibitor monotherapy: Impact on renal function

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 34, Núm. 1, pp. 29-32

  2. Topical cidofovir to treat high-grade anal intraepithelial neoplasia in HIV-infected patients: A pilot clinical trial

    AIDS, Vol. 30, Núm. 1, pp. 75-82

2014

  1. A comparative study of neurocognitively impaired patients receiving protease inhibitor monotherapy or triple-drug antiretroviral therapy

    Journal of Acquired Immune Deficiency Syndromes

  2. A prospective cohort study of neurocognitive function in aviremic HIV-infected patients treated with 1 or 3 antiretrovirals

    Clinical Infectious Diseases, Vol. 59, Núm. 11, pp. 1627-1634

  3. Incidence of Hepatitis C Virus (HCV) in a multicenter cohort of HIV-positive patients in Spain 2004-2011: Increasing rates of HCV diagnosis but not of HCV seroconversions

    PLoS ONE, Vol. 9, Núm. 12

  4. Inflammatory, procoagulant markers and HIV residual viremia in patients receiving protease inhibitor monotherapy or triple drug therapy: A cross-sectional study

    BMC Infectious Diseases, Vol. 14, Núm. 1

  5. Pattern of neurocognitive function in patients receiving boosted protease inhibitor monotherapy: A detailed neuropsychological study

    Journal of NeuroVirology, Vol. 20, Núm. 4, pp. 362-370

  6. Tuberculosis in a cohort of HIV-positive patients: Epidemiology, clinical practice and treatment outcomes

    International Journal of Tuberculosis and Lung Disease, Vol. 18, Núm. 6

2013

  1. Is etravirine and two nucleosides an option for HIV with an isolated K103N mutation?

    AIDS, Vol. 27, Núm. 1, pp. 141-144

  2. Neurocognitive Impairment in Patients Treated with Protease Inhibitor Monotherapy or Triple Drug Antiretroviral Therapy

    PLoS ONE, Vol. 8, Núm. 7